Skip to main content
SpringerLink
Log in

Endocrine Regulation of Fetal Growth

  • Chapter
  • First Online:
Caring for Children Born Small for Gestational Age

  • 953 Accesses

Abstract

Substantial evidence in the past decade has linked changes in the in utero environment and nutrition to pubertal and adult diseases in later life. As early as 1962, JV Neel, an American population geneticist, proposed the concept of the ‘thrifty genotype’, which is described as metabolic characteristics that arise during famine to guarantee survival but which later become harmful during nutritional abundance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353-362.

    Google Scholar 

  2. Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006;49:270-283.

    Google Scholar 

  3. Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007; 261:412-417.

    Google Scholar 

  4. Barker DJ, Winter PD, Osmond C, et al. Weight in infancy and death from ischemic heart disease. Lancet. 1989;2:577-580.

    Google Scholar 

  5. Eriksson JG, Osmond C, Kajantie E, et al. Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia. 2006;49:2853-2858.

    Google Scholar 

  6. Low JA, Handley-Derry MH, Burke SO, et al Association of intrauterine fetal growth retardation and learning deficits at age 9 to 11 years. Am J Obstet Gynecol. 1992;167:1499-1505.

    Google Scholar 

  7. Taylor DJ, Howie PW. Fetal growth achievement and neurodevelopmental disability. Br J Obstet Gynecol. 1989;96:789-794.

    Google Scholar 

  8. Paz I, Gale R, Laor A, et al The cognitive outcome of full term small for gestational age infants at late adolescence. Obstet Gynecol. 1995;85:452-456.

    Google Scholar 

  9. Oyen N, Skjaerven R, Little RE, et al Fetal growth retardation in sudden infant death syndrome (SIDS) babies and their siblings. Am J Epidemiol. 1995;142:84-90.

    Google Scholar 

  10. Chernausek SD. Update: consequences of abnormal fetal growth. J Clin Endocrinol Metab. 2012;97:689-695.

    Google Scholar 

  11. Gluckman PD, Hanson MA. The developmental origins of health and disease: the breadth and importance of the concept. In: Early Life Origins of Health and Disease. New York, NY: Springer. 2006; 1-7.

    Google Scholar 

  12. Leger J, Levy-Marchal C, Bloch J, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ. 1997;315:341-347.

    Google Scholar 

  13. Saenger P, Czernichow P, Hughes I, et al. Small for gestational age: short stature and beyond. Endocrine Reviews. 2007;28:219-251.

    Google Scholar 

  14. Jaquet D, Deghmoun S, Chevenne D, et al. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia. 2005;48:849-855.

    Google Scholar 

  15. Levy-Marchal C, Czernichow P. Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies? Horm Res. 2006;65 (suppl 3):123-130.

    Google Scholar 

  16. Soto N, Bazaes RA, Pena V, et al. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab. 2003;88:3645-3650.

    Google Scholar 

  17. Yajnik CS, Lubree HG, Rege SS, et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab. 2002;87:5575-5580.

    Google Scholar 

  18. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab. 2002;87:4657-4661.

    Google Scholar 

  19. Siahanidou T, Mandyla H, Papassotiriou GP, Papassotiriou I, Chrousos G. Circulating levels of adiponectin in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2007;92:F286-F290.

    Google Scholar 

  20. Jaquet D, Deghmoun S, Chevenne D, et al. Low serum adiponectin levels in subjects born small for gestational age: impact on insulin sensitivity. Int J Obes (London). 2006;30:83-87.

    Google Scholar 

  21. Reinehr T, Kleber M, Toschke AM. Small for gestational age status is associated with metabolic syndrome in overweight children. Eur J Endocrinol. 2009;160:579-584.

    Google Scholar 

  22. Brufani C, Grossi A, Fintini D, et al. Obese children with low birth demonstrate impaired β-cell funcion during oral glucose tolerance test. J Clin Endocrinol Metab. 2009;94:4448-4452.

    Google Scholar 

  23. Leunissen RW, Kerkhof GF, Stijnen T, et al. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA. 2009;301:2234-2242.

    Google Scholar 

  24. Leipala JA, Raivio KO, Sarnesto A, et al. Intrauterine growth restriction and postnatal steroid treatment effects on insulin sensitivity in preterm neonates. J Pediatr. 2002;14:473-476.

    Google Scholar 

  25. Beringue F, Bertrand B, Castelotti MC, et al. Endocrine pancreas development in growthretarded human fetuses. Diabetes. 2002;53:385-391.

    Google Scholar 

  26. Kyriakakou M, Malamitsi-Puchner A, Militsi H et al. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers. Eur J Endocrinol. 2008;158:343-348.

    Google Scholar 

  27. Briana DD, Milamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol. 2009;160:337-347.

    Google Scholar 

  28. Fall CHD, Barker DJ, Osmond C, et al. Relation of infant feeding to adult serum cholesterol concentration and death from ischemic heart disease. BMJ. 1992;304:801-805.

    Google Scholar 

  29. Barker DJP, Meade TW, Fall CH, et al. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ. 1992;304:801-805.

    Google Scholar 

  30. Meas T, Deghmoun S, Alberti C, et al. Independent effects of weight gain and fetal programming on metabolic complications in adults born small for gestational age. Diabetologia. 2010;53:907-913.

    Google Scholar 

  31. Vickers MH, Gluckman PD, Coveny AH, et al. Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005;146:4211-4216.

    Google Scholar 

  32. Singhal A, Fewtrell M, Cole TJ, et al. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet. 2003;361:1089-1097.

    Google Scholar 

  33. Hales CN, Barker DJ, Clark PM, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019-1022.

    Google Scholar 

  34. Williams JPG. Catch-up growth. J Embryol Exp Morphol. 1981;65(suppl):89-101.

    Google Scholar 

  35. Prader A, Tanner JM, Von Harnack GA. Catch-up growth following illness or starvation. J Pediatrics. 1963;62:646-659.

    Google Scholar 

  36. Boersma B, Wit JM. Catch-up growth. Endocr Rev. 1997;18:646-661.

    Google Scholar 

  37. Lui J, Baron J. Mechanisms limiting body growth in mammals. Endocr Rev. 2011;32:422-440.

    Google Scholar 

  38. Gafni RI, Baron J. Catch-up growth: possible mechanisms. Pediatr Nephrol. 2000;14:616-619.

    Google Scholar 

  39. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, et al Children born small for gestational age: do they catch up? Pediatr Res. 1995;38:267-271.

    Google Scholar 

  40. Ong KK, Ahmed ML, Emmett PM, et al. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ. 2000;320:967-971.

    Google Scholar 

  41. Albertsson-Wikland K, Karlberg J. Postnatal growth of children born small for gestational age. Acta Paediatr Suppl. 1997;423:193-195.

    Google Scholar 

  42. Gillman MW. Developmental origins of health and disease. N Engl J Med. 2005;353:1848-1850.

    Google Scholar 

  43. Cianfarani S, Germani D, Rossi P, et al. Intrauterine growth retardation: evidence for the activation of the insulin-like growth factor (IGF)-related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolytic activity by two months of life. Pediatr Res. 1998;44:374-380.

    Google Scholar 

  44. Leger J, Noel M, Limal JM, et al. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) 1, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study group of IUGR. Pediatr Res. 1996;40:101-107.

    Google Scholar 

  45. de Zegher F, Kimpen J, Raus J, et al. Hypersomatotropism in the dysmature infant at term and preterm birth. Biol Neonate. 1990;58:188-191.

    Google Scholar 

  46. Deiber M, Chatelain P, Naville D, et al. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J Clin Endocrinol Metab. 1989;68:232-234.

    Google Scholar 

  47. Grunt JA, Howard CP, Daughaday WH. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism. Acta Endocrinol (Copenh). 1984;106:168-174.

    Google Scholar 

  48. Arends N, Johnston L, Hokken-Koelega A, et al. Polymorphism in the IGF-1 gene: clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab. 2002;87:2720.

    Google Scholar 

  49. Johnston LB, Dahlgren J, Leger J, et al. Association between insulin-like growth factor 1 (IGF-1) polymorphisms, circulating IGF-1, and pre- and postnatal growth in two European small for gestational age populations. J Clin Endocrinol Metab. 2003;88:2699-2705.

    Google Scholar 

  50. Woods KA, Camacho-Hubner C, Savage MO, et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor 1 gene. N Engl J Med. 1996; 335:1363-1367.

    Google Scholar 

  51. Abuzzahab MJ, Schneider A, Goddard A, et al. IGF-1 receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med. 2003;349:2211-2222.

    Google Scholar 

  52. Giudice LC, de Zegher F, Gargosky SE, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 1995;80:1548-1555.

    Google Scholar 

  53. Cianfarani S, Geremia C, Scott CD, et al. Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis? Pediatr Res. 2002;51:94-99.

    Google Scholar 

  54. Cianfarani S, Maiorana A, Geremia C, et al. Blood glucose concentrations are reduced in children born small for gestational age (SGA), and thyroid-stimulating hormone levels are increased in SGA with blunted postnatal catch-up growth. J Clin Endocrinol Metab. 2003;88:2699-2705.

    Google Scholar 

  55. Constancia M, Hemberger M, Hughes J, et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature. 2002;417:945-948.

    Google Scholar 

  56. Verkauskiene R, Jaquet D, Deghmoun S, et al. Smallness for gestational age is associated with persistent change in insulin-like growth factor 1 (IGF-1) and the ratio of IGF1/IGF-binding protein-3 in adulthood. J Clin Endocrinol Metab. 2005;90:5672-5676.

    Google Scholar 

  57. Dorr HG, Bettendorf M, Hauffa BP, et al. Different relationships between the first two years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children. Clin Endocrinol (Oxf). 2011;75:656-660.

    Google Scholar 

  58. Lango AH, Estrada K, Lettre G, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010;467:832-838.

    Google Scholar 

  59. Huber C, Munnich A, Cormier-Daire V, et al. The 3 M syndrome. Best Pract Res Clin Endocrinol Metab. 2011;25:143-151.

    Google Scholar 

  60. Hanson D, Murray PG, O’Sullivan J, et al. Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth. Am J Hum Genet. 2011;89:148-153.

    Google Scholar 

  61. Ranke MB, Lindberg A. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS. Horm Res Pediatr. 2010;74:259-266.

    Google Scholar 

  62. Toumba M, Albanese A, Azcona C, et al. Effect of long-term growth hormone treatment on final height of children with Russell-Silver syndrome. Horm Res Pediatr. 2010;74:212-217.

    Google Scholar 

  63. Ranke MB, Lindberg A. Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database). BMC Med Inform Decis Mak. 2011;11:38.

    Google Scholar 

  64. Ibanez L, Lopez-Bermejo A, Diaz M, et al. Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin. J Clin Endocrinol Metab. 2010;95:2234-2239.

    Google Scholar 

  65. Levine S. Maternal and environmental influences on the adrenocortical response to stress in weanling rats. Science. 1967;156:258-260.

    Google Scholar 

  66. Cianfarani S, Ladaki C, Geremia C. Hormonal regulation of postnatal growth in children born small for gestational age. Horm Res. 2006;65(suppl 3):70-74.

    Google Scholar 

  67. Reynolds RM, Walker BR, Syddall HE, et al. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab. 2001;86:245-250.

    Google Scholar 

  68. Tenhola S, Martikainen A, Rahiala E, et al Increased adrenocortical and adrenomedullary hormonal activity in 12-year-old children born small for gestational age. J Pediatr. 2002;141:477-482.

    Google Scholar 

  69. Ibanez L, Potau N, Marcos MV, et al. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche. J Clin Endocrinol Metab. 1999;84:4602-4606.

    Google Scholar 

  70. Kilby MD, Verhaeg J, Gittoes N, et al. Circulating thyroid hormone concentrations and placental thyroid hormone receptor expression in normal human pregnancy and pregnancy complicated by intrauterine growth restriction (IUGR). J Clin Endocrinol Metab. 1998;83:2964-2971.

    Google Scholar 

  71. Kilby MD, Gittoes N, McCabe C, et al. Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin Endocrinol (Oxf). 2000;53:469-477.

    Google Scholar 

  72. de Kort SW, Willemsen RH, van der Kaay DC, et al. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment. Clin Endocrinol (Oxf). 2008;69:318-322.

    Google Scholar 

  73. Hernandez MI, Martinez A, Capurro T, et al. Comparison of clinical, ultrasonographic, and biochemical differences at the beginning of puberty in healthy girls born either small for gestational age or appropriate for gestational age: preliminary results. J Clin Endocrinol Metab. 2006;91:3377-3381.

    Google Scholar 

  74. Veening MA, Van Weissenbruch MM, Roord JJ, et al. Pubertal development in children born small for gestational age. J Pediatr Endocrinol Metab. 2004;17:1497-1505.

    Google Scholar 

  75. Ibanez L, Lopez-Bermejo A, Diaz M, et al. Early metformin therapy (age 8–12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J Clin Endocrinol Metab. 2011;96:E1262-E1267.

    Google Scholar 

  76. Legro RS, Roller RL, Dodson WC, et al. Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. J Clin Endocrinol Metab. 2010;95:789-799.

    Google Scholar 

  77. Jaquet D, Leger J, Chevenne D, et al. Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women. J Clin Endocrinol Metab. 1999;84:3945-3949.

    Google Scholar 

  78. Skakkebaek NE. Testicular dysgenesis syndrome: new epidemiological evidence. Int J Androl. 2004;27:189-191.

    Google Scholar 

  79. Bay K, Asklund C, Skakkebaek NE, Andersson AM. Testicular dysgenesis syndrome: possible role of endocrine disrupters. Best Pract Res Clin Endocrinol Metab. 2006;20:77-90.

    Google Scholar 

  80. Main KM, Jensen RB, Asklund C, Hoi-Hansen CE, Skakkebaek NE. Low birth weight and male reproductive function. Horm Res. 2006;65(suppl 3):116-122.

    Google Scholar 

  81. Barker DJ. Mothers, babies, and disease later in life. Second edn. London: Elsevier Health Sciences; 1998.

    Google Scholar 

  82. Martyn C, Barker D, Osmond C. Mother’s pelvic size, fetal growth and death from stroke in men. Lancet. 1996;348:1264-1268.

    Google Scholar 

  83. Andersen A-M, Ostler M. Birth dimensions, parental mortality, and mortality in early adult age: a cohort study of Danish men born in 1953. Int J Epidemiol. 2004;33:92-99.

    Google Scholar 

  84. Barker DJ, Godfrey KM, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991;303:671-675.

    Google Scholar 

  85. Lackland DT, Bendall HE, Osmond C, et al. Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch Intern Med. 2000;160:1472-1476.

    Google Scholar 

  86. Hoy WE, Rees M, Kile E, et al. A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. Kidney Int. 1999;56:1072-1077.

    Google Scholar 

  87. Zandi-Nejad K, Luyckx VA, BrennerBM. Adult hypertension and kidney disease: the role of fetal programming. Hypertension. 2006;47:502-508.

    Google Scholar 

  88. Keijzer-Veen MG, Schrevel M, Finken MJ, et al; Dutch POPS-19 Collaborative Study Group. Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol. 2005;16:2762-2768.

    Google Scholar 

  89. Sheu JN, Chen JH. Minimal change nephrotic syndrome in children with intrauterine growth retardation. Am J Kidney Dis. 2001;37:909-914.

    Google Scholar 

  90. Na YW, Yang HJ, Choi JH, et al. Effect of intrauterine growth retardation on the progression of nephrotic syndrome. Am J Nephrol. 2002;22:463-467.

    Google Scholar 

  91. Sharma P, McKay K, Rosenkrantz TS, et al. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants. BMC Pediatr. 2004;4:9.

    Google Scholar 

  92. Harding R, Tester M, Moss T, et al. Effects of intra-uterine growth restriction on the control of breathing and lung development after birth. Clin Exp Pharmacol Physiol. 2000;27:114-119.

    Google Scholar 

  93. Cole TJ. Secular trends in growth. Proc Nutr Soc. 2000;59:317-324.

    Google Scholar 

  94. Tobias JH, Cooper C. PTH/PTHrP activity and the programming of skeletal development in utero. J Bone Miner Res. 2004;19:177-182.

    Google Scholar 

  95. Arends NJ, Boonstra VH, Mulder PG, et al. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial. Clin Endocrinol (Oxf). 2003;59:779-787.

    Google Scholar 

  96. Cooper C, Eriksson JG, Forsen T, et al. Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int. 2001;12:623-629.

    Google Scholar 

  97. Sas T, de Waal W, Mulder P, et al. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab. 1999;84:3064-3070.

    Google Scholar 

  98. McCarton CM, Wallace IF, Divon M, et al. Cognitive and neurologic development of the premature, small for gestational age infant through age 6: comparison by birth weight and gestational age. Pediatrics. 1996;98:1167-1178.

    Google Scholar 

  99. Strauss RS. Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort. JAMA. 2000;283:625-632.

    Google Scholar 

  100. Lundgren EM, Cnattingius S, Jonsson B, et al. Intellectual and psychological performance in males born small for gestational age with and without catch-up growth. Pediatr Res. 2001;50:91-96.

    Google Scholar 

  101. Sebert S, Sharkey D, Budge H, et al. The early programming of metabolic health: is epigenetic setting the missing link? Am J Clin Nutr. 2011;94:1953S-1958S.

    Google Scholar 

  102. Park JH, Stoffers DA, Nicholls RD, et al. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008;118:2316-2324.

    Google Scholar 

  103. Pinney SE, Jaeckle Santos LJ, Han Y, et al. Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat. Diabetologia. 2011;54:2606-2614.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut for Pediatric Endocrinology and Preventive Medicine, Im Fuchstal 8, 66424, Homburg, Germany

    Siegfried Zabransky

Authors
  1. Siegfried Zabransky
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hamburg, Hamburg, Germany

    Siegfried Zabransky

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Healthcare

About this chapter

Cite this chapter

Zabransky, S. (2013). Endocrine Regulation of Fetal Growth. In: Zabransky, S. (eds) Caring for Children Born Small for Gestational Age. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-908517-90-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-908517-90-6_14

  • Published:

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-908517-85-2

  • Online ISBN: 978-1-908517-90-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation